Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
16
datasets available to search
ShareScore release 0.9.0
Dataset results
16 results for “medical marijuana”
Characteristics of medical marijuana dispensary patients
<p><strong>Introduction</strong>: <span>Despite the rising availability and use of medical marijuana (MM) in the U.S., little is known about the demographics, clinical characteristics, or quality of life of MM patients. This study describes the demographic characteristics and health-related quality of life (HRQoL) of MM patients who are initiating treatment in Pennsylvania.</span></p> <p><strong>Methods</strong>: Two hundred<span> adults naive to MM and referred for any of the 23 state-approved qualifying conditions were recruited at three MM dispensaries in Pennsylvania between September 2020 and March 2021. All participants consented to the study, completed semi-structured interviews that included demographic questionnaires, the Short Form-36 (SF-36), and Generalized Anxiety Disorder-7 (GAD-7), provided height and weight measurements, and allowed access to their dispensary medical records. </span></p> <p><strong>Results</strong>: <span>Participants had a mean age of 48.5 ±15.6 years, predominantly identified as female (67.5 %), and were most commonly referred for chronic pain (63.5%) and/or anxiety (58.5%). Additionally, 46.0% were living with obesity as determined by Body Mass Index (BMI). Relative to a normative sample, participants reported diminished HRQoL in several domains, most notably in role limitations due to physical health (M = 46.0 ± 42.0), role limitations due to emotional problems (M = 52.5 ± 42.3), energy and fatigue (M = 39.8 ± 20.2), and pain (M = 49.4 ± 26.0).</span></p> <p><strong>Discussion/Conclusion</strong>: <span>Patients initiating MM treatment experienced low HRQoL in multiple domains. Future studies could evaluate the relationship between HRQoL and patients' decisions to pursue MM treatment, as well as changes in HRQoL with MM use over time.</span></p>
Weight stability in adults with obesity initiating medical marijuana treatment
<p>Few studies have evaluated weight change in patients who initiate medical marijuana treatment to address diagnosed health concerns. The objective of this study was to examine whether patients initiating medical marijuana use for a qualifying health condition experienced changes in health and biopsychosocial functioning over time, including weight gain or loss. Specifically, this observational, longitudinal study evaluated changes in the Body Mass Index (BMI) of adults with co-morbid obesity (Body Mass Index [BMI] ≥ 30 kg/m2) and severe obesity (BMI ≥ 40 kg/m2) who were starting medical marijuana treatment for any of the 23 qualifying medical conditions at one of three dispensaries in Pennsylvania. Height and weight measurements were collected at baseline (prior to medical marijuana use) and then 90 days (± 14 days) later. Participants included in analyses (n = 52, M = 55.0 ± 13.6 years, 59.6% female) had a mean baseline BMI of 36.2 ± 5.4 kg/m2 and the majority sought medical marijuana for chronic pain (73.1%). No significant change in BMI was observed from baseline to month three (p > 0.05) in the sample. Additionally, no significant change in BMI was observed in the subset of patients with severe obesity (n = 12, p > 0.05). Our findings are limited by low follow-up rates and convenience sampling methodology but may help to mitigate weight gain concerns in the context of medical marijuana use.</p>
The Effect of Prescription Medications in Marijuana Users
ClinicalTrials.gov study NCT00893074. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Effect of Medical Marijuana on Neurocognition and Escalation of Use
ClinicalTrials.gov study NCT03224468. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Weight stability in adults with obesity initiating medical marijuana treatment
Open the record for dataset details and reuse information.
Characteristics of medical marijuana dispensary patients
Open the record for dataset details and reuse information.
Medical Marijuana and Open Road Driving Task
ClinicalTrials.gov study NCT06995937. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
ClinicalTrials.gov study NCT01536899. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep
ClinicalTrials.gov study NCT00893269. IPD Sharing: Not stated. Countries: 1. Publications: 2.
MEMO-Medical Marijuana and Opioids Study
ClinicalTrials.gov study NCT03268551. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
ClinicalTrials.gov study NCT03172741. IPD Sharing: NO. Countries: 0. Publications: 3.
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
ClinicalTrials.gov study NCT02898974. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana
ClinicalTrials.gov study NCT04083261. IPD Sharing: NO. Countries: 1. Publications: 0.
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
ClinicalTrials.gov study NCT03052738. IPD Sharing: NO. Countries: 1. Publications: 0.
Medical Marijuana Use in HIV+ Patients: Probability Survey
ClinicalTrials.gov study NCT01536912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
ClinicalTrials.gov study NCT04226690. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.